Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Yuxi Pharmaceutical Technology is a specialized pharmaceutical service provider and high-tech enterprise headquartered in Nanjing, China. The company focuses on the research, development, and production of high-end pharmaceutical intermediates, API impurity standards, and stable isotope-labeled compounds. Nanjing Yuxi offers comprehensive CRO and CDMO services, including custom synthesis, process development, and analytical testing to support global drug discovery efforts. Their expertise lies in complex small molecule chemistry, providing critical reference materials for pharmaceutical quality control and regulatory compliance. The firm serves a diverse clientele ranging from academic institutions to large-scale pharmaceutical manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanjing Yuxi Pharmaceutical Technology.